|
|
 |
|
|
|
 |
| Market Cap | 2.23B | EPS (ttm) | -0.78 |
| P/E | - | EPS this Y | - |
| Forward P/E | - | EPS next Y | - |
| PEG | - | EPS past 5Y | - |
| P/S | - | EPS next 5Y | - |
| P/B | - | EPS Q/Q | -794.80% |
| Dividend | - | Sales Q/Q | - |
| Insider Own | - | Inst Own | - |
| Insider Trans | - | Inst Trans | - |
| Short Float | 1.53% | Earnings | - |
| Analyst Recom | - | Target Price | - |
| Avg Volume | 3.33M | 52W Range | 20.25 - 66.67 |
|
|
|
|
| Nano-X Imaging Ltd. engages in developing and producing X-ray source technology for the medical imaging industry in the United States. It develops novel digital X-ray source, a microelectromechanical system-based semiconductor cathode that achieves electron emission by a non-thermionic low-voltage trigger to nano-scale molybdenum cones. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud software designed to deliver medical screening as a service. Nano-X Imaging Ltd. was incorporated in 2018 and is based in Neve Ilan, Israel. |
|
|
 |
| Market Cap | 91.70M | EPS (ttm) | -0.55 |
| P/E | - | EPS this Y | -123.20% |
| Forward P/E | - | EPS next Y | 116.50% |
| PEG | - | EPS past 5Y | - |
| P/S | 1.18 | EPS next 5Y | - |
| P/B | 1.27 | EPS Q/Q | -59.30% |
| Dividend | - | Sales Q/Q | -19.30% |
| Insider Own | 0.22% | Inst Own | 0.90% |
| Insider Trans | 0.00% | Inst Trans | 17.34% |
| Short Float | 0.05% | Earnings | Jul 02/b |
| Analyst Recom | 2.00 | Target Price | - |
| Avg Volume | 18.24K | 52W Range | 1.01 - 3.00 |
|
|
|
|
| TuanChe Limited, through with its subsidiaries, operates as an omni-channel automotive marketplace in China. It organizes auto shows and group-purchase events that attract various consumers; and provides integrated marketing solutions to industry customers, which include automakers, franchised dealerships, secondary dealers, and automotive service providers, as well as enable interactions between participants on both sides of a potential transaction. As of December 31, 2019, the company organized 1,055 auto shows in 233 cities across China. It also provides virtual dealership services by connecting automakers and franchised dealerships with secondary dealers by providing a suite of services traditionally undertaken by franchised dealerships without setting up permanent physical presence. In addition, the company offers business and technical support, and consulting services. TuanChe Limited has a strategic partnership with Beijing Easyhome Furnishing Chain Group Co., Ltd. to jointly establish an one-stop retail experience that combines home decoration products and automotive services. The company was founded in 2010 and is headquartered in Beijing, China. |
|
|
 |
| Market Cap | 249.80M | EPS (ttm) | -1.60 |
| P/E | - | EPS this Y | -240.10% |
| Forward P/E | - | EPS next Y | - |
| PEG | - | EPS past 5Y | - |
| P/S | 0.39 | EPS next 5Y | -13.22% |
| P/B | 0.21 | EPS Q/Q | - |
| Dividend | - | Sales Q/Q | -54.40% |
| Insider Own | - | Inst Own | 5.60% |
| Insider Trans | - | Inst Trans | 0.35% |
| Short Float | 0.09% | Earnings | - |
| Analyst Recom | 3.00 | Target Price | - |
| Avg Volume | 1.11M | 52W Range | 0.95 - 13.80 |
|
|
|
|
| 9F Inc., together with its subsidiaries, operates a digital financial account platform that integrates and personalizes financial services in the People's Republic of China. Its products include digital financial accounts that offer online lending, online wealth management, and payment facilitation services; revolving and non-revolving loan products to borrowers, as well as traffic referral services to institutional funding partners; and a suite of online wealth management products, such as fixed income products, stocks, insurance, and mutual funds to investors in various platforms, including Wukong Licai, 9F Wallet, and 9F Puhui. The company also provides payment facilitation and other products and services that help users to pay credit card bills and household bills, such as utility bills; and other value-added services, including credit history search, debt consolidation, and user referral services. It has partnerships with borrowers, investors, financial institutions, and merchant partners. The company was formerly known as JIUFU Financial Technology Service Limited and changed its name to 9F Inc. in June 2014. 9F Inc. was founded in 2006 and is headquartered in Beijing, the People's Republic of China. |
|
|
 |
| Market Cap | 326.30M | EPS (ttm) | 0.18 |
| P/E | 75.75 | EPS this Y | 26.40% |
| Forward P/E | 5.26 | EPS next Y | 42.46% |
| PEG | - | EPS past 5Y | -22.60% |
| P/S | 12.70 | EPS next 5Y | - |
| P/B | 11.33 | EPS Q/Q | 648.70% |
| Dividend | - | Sales Q/Q | 45444.90% |
| Insider Own | 24.21% | Inst Own | 29.10% |
| Insider Trans | -1.71% | Inst Trans | 194.74% |
| Short Float | 31.28% | Earnings | Aug 13/a |
| Analyst Recom | 2.00 | Target Price | - |
| Avg Volume | 4.19M | 52W Range | 0.85 - 30.99 |
|
|
|
|
| Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| SERBIN RICHARD S | Director | May 28 | Option Exercise | 3.96 | 25,000 | 99,000 | 25,000 | Jun 05 05:48 PM | | SERBIN RICHARD S | Director | May 28 | Sale | 18.02 | 25,000 | 450,525 | 0 | Jun 05 05:49 PM | | Durenard Eugene | Director | May 26 | Sale | 18.26 | 25,000 | 456,500 | 0 | Jun 05 05:51 PM | | Durenard Eugene | Director | May 20 | Option Exercise | 2.34 | 50,000 | 116,750 | 25,000 | Jun 04 02:34 PM | | Durenard Eugene | Director | May 20 | Sale | 18.40 | 25,000 | 460,000 | 0 | Jun 05 05:51 PM |
|
|
|
 |
| Market Cap | 953.56M | EPS (ttm) | -7.95 |
| P/E | - | EPS this Y | -125.10% |
| Forward P/E | 47.77 | EPS next Y | 120.50% |
| PEG | - | EPS past 5Y | -1.40% |
| P/S | 0.51 | EPS next 5Y | - |
| P/B | 7.82 | EPS Q/Q | -78.60% |
| Dividend | - | Sales Q/Q | -25.70% |
| Insider Own | 7.10% | Inst Own | 55.50% |
| Insider Trans | 148.77% | Inst Trans | -5.72% |
| Short Float | 13.60% | Earnings | Aug 06/a |
| Analyst Recom | 2.90 | Target Price | 26.59 |
| Avg Volume | 2.88M | 52W Range | 9.60 - 63.20 |
|
|
|
|
| Groupon, Inc. operates online local commerce marketplaces that connect merchants to consumers by offering goods and services at a discount in North America and internationally. The company provides deals in various categories, including events and activities; health, beauty, and wellness; food and drink; home and garden; automotive; discounted and market rates for hotel, airfare, and package deals, as well as deals on various product lines, such as electronics, sporting goods, jewelry, toys, household items, and apparel. It offers its deal offerings to customers through Websites; search engines; mobile applications and mobile, which enable consumers to browse, purchase, manage, and redeem deals on their mobile devices; emails and push notifications; affiliate channels; social and display advertising; and offline marketing. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was founded in 2008 and is headquartered in Chicago, Illinois. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Thomas Melissa | Chief Financial Officer | Sep 05 | Option Exercise | 0.00 | 167 | 0 | 9,288 | Sep 09 05:44 PM | | Thomas Melissa | Chief Financial Officer | Aug 23 | Option Exercise | 0.00 | 4,863 | 0 | 11,276 | Aug 25 05:30 PM | | LEFKOFSKY ERIC P | Director | Jun 18 | Buy | 21.57 | 250,000 | 5,391,550 | 34,134,994 | Jun 22 06:06 PM | | Drobny Dane A | Chief Admin Officer, GC & Sec | Jun 05 | Option Exercise | 0.00 | 73,619 | 0 | 899,163 | Jun 09 06:07 PM | | Gangadharan Manjunath | Chief Accounting Officer | Jun 05 | Option Exercise | 0.00 | 14,457 | 0 | 54,937 | Jun 09 06:08 PM |
|
|
|
 |
| Market Cap | 519.33M | EPS (ttm) | -0.52 |
| P/E | - | EPS this Y | -439.60% |
| Forward P/E | - | EPS next Y | - |
| PEG | - | EPS past 5Y | - |
| P/S | - | EPS next 5Y | - |
| P/B | 4.33 | EPS Q/Q | -304.40% |
| Dividend | - | Sales Q/Q | - |
| Insider Own | 5.86% | Inst Own | 96.21% |
| Insider Trans | -75.12% | Inst Trans | -40.45% |
| Short Float | 4.19% | Earnings | - |
| Analyst Recom | - | Target Price | - |
| Avg Volume | 1.29M | 52W Range | 9.87 - 32.50 |
|
|
|
|
| Graf Industrial Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with industrial companies in diversified industrial manufacturing, technology, distribution, and service businesses in the United States and Canada. The company was founded in 2018 and is based in Houston, Texas. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| GLAZER CAPITAL, LLC | 10% Owner | Jul 02 | Sale | 17.72 | 3,181,052 | 56,367,431 | 747,118 | Jul 02 07:39 PM |
|
|
|
 |
| Market Cap | 361.46M | EPS (ttm) | 2.68 |
| P/E | 9.62 | EPS this Y | 453.00% |
| Forward P/E | 7.40 | EPS next Y | 4.87% |
| PEG | - | EPS past 5Y | - |
| P/S | 0.38 | EPS next 5Y | - |
| P/B | 2.17 | EPS Q/Q | 2.30% |
| Dividend | - | Sales Q/Q | 48.60% |
| Insider Own | 0.60% | Inst Own | 83.00% |
| Insider Trans | 0.00% | Inst Trans | 0.66% |
| Short Float | 7.64% | Earnings | Jul 30/b |
| Analyst Recom | 2.30 | Target Price | 32.67 |
| Avg Volume | 60.46K | 52W Range | 3.41 - 33.60 |
|
|
|
|
| OneWater Marine Inc. operates as a recreational boat retailer in the United States. It offers new and pre-owned recreational boats and yachts, as well as related marine products, such as parts and accessories. The company also provides boat repair and maintenance services; arranges boat financing and insurance; and other ancillary services, including indoor and outdoor storage, and marina, as well as rental of boats and personal watercraft. As of October 21, 2019, it operated 63 stores comprising 21 dealer groups in 11 states. The company was founded in 2014 and is headquartered in Buford, Georgia. |
|
|
 |
| Market Cap | 6.39M | EPS (ttm) | -9.85 |
| P/E | - | EPS this Y | 31.00% |
| Forward P/E | - | EPS next Y | 23.90% |
| PEG | - | EPS past 5Y | -49.50% |
| P/S | 0.12 | EPS next 5Y | 15.00% |
| P/B | - | EPS Q/Q | -245.90% |
| Dividend | - | Sales Q/Q | -25.70% |
| Insider Own | 1.02% | Inst Own | 49.40% |
| Insider Trans | 0.00% | Inst Trans | -9.98% |
| Short Float | 15.75% | Earnings | Aug 19/b |
| Analyst Recom | 3.00 | Target Price | - |
| Avg Volume | 305.65K | 52W Range | 1.04 - 10.90 |
|
|
|
|
| Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. The company's topical semi-solid and liquid products are used in various applications that range from cosmetics and cosmeceuticals; and the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. It sells its products through national chain drug stores, drug wholesalers, distributors, and group purchasing organizations. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey. |
|
|
 |
| Market Cap | 5.99M | EPS (ttm) | -2.46 |
| P/E | - | EPS this Y | -263.90% |
| Forward P/E | - | EPS next Y | - |
| PEG | - | EPS past 5Y | -27.30% |
| P/S | 0.84 | EPS next 5Y | - |
| P/B | 0.34 | EPS Q/Q | -136.30% |
| Dividend | - | Sales Q/Q | -93.90% |
| Insider Own | 29.13% | Inst Own | 0.90% |
| Insider Trans | 0.00% | Inst Trans | 241.69% |
| Short Float | 0.32% | Earnings | - |
| Analyst Recom | - | Target Price | - |
| Avg Volume | 98.28K | 52W Range | 1.40 - 4.89 |
|
|
|
|
| Sino-Global Shipping America, Ltd. provides shipping and freight logistics integrated solutions in the United States, China, and Hong Kong. Its services include shipping agency, inland transportation management, freight logistics, and container trucking services. The company was founded in 2001 and is headquartered in Roslyn, New York. |
|
|
 |
| Market Cap | 499.54M | EPS (ttm) | -2.26 |
| P/E | - | EPS this Y | -10.60% |
| Forward P/E | - | EPS next Y | 19.80% |
| PEG | - | EPS past 5Y | -27.10% |
| P/S | 111.01 | EPS next 5Y | - |
| P/B | 3.80 | EPS Q/Q | 40.50% |
| Dividend | - | Sales Q/Q | -61.90% |
| Insider Own | 1.10% | Inst Own | 90.10% |
| Insider Trans | 406.16% | Inst Trans | 6.37% |
| Short Float | 10.48% | Earnings | Aug 06/b |
| Analyst Recom | 1.40 | Target Price | - |
| Avg Volume | 902.60K | 52W Range | 3.24 - 14.68 |
|
|
| Sep-14-20 | Downgrade |
Jefferies |
Buy → Hold |
$10 |
|
|
|
|
| Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. The company's lead product candidate is KPI-121 0.25% which has completed two Phase III clinical trials for the treatment of temporary relief of the signs and symptoms of dry eye disease; INVELTYS which has completed two Phase III clinical trials for the treatment of inflammation and pain following ocular surgery; and KPI-285, a MPP receptor tyrosine kinase inhibitor program, which is in preclinical studies for the treatment of retinal diseases. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. was founded in 2009 and is headquartered in Watertown, Massachusetts. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Trachtenberg Eric | See Remarks | Jun 19 | Option Exercise | 5.19 | 28,901 | 149,996 | 28,901 | Jun 22 04:06 PM | | Reumuth Mary | Chief Financial Officer | Jun 09 | Option Exercise | 2.64 | 43,477 | 114,771 | 48,293 | Jun 11 04:58 PM | | Brazzell Romulus K | Chief Medical Officer | Apr 09 | Option Exercise | 2.99 | 67,771 | 202,377 | 176,496 | Apr 13 08:38 AM | | Chen Hongming | Chief Scientific Officer | Mar 30 | Option Exercise | 2.30 | 31,000 | 71,300 | 86,849 | Apr 01 04:43 PM | | Bazemore Todd | Chief Operating Officer | Mar 16 | Buy | 5.75 | 10,000 | 57,500 | 10,000 | Mar 17 05:46 PM |
|
|
|
|
123456next
|
|
|
